Zephyrnet Logo

Tag: NK

Universal STING mimic boosts antitumour immunity via preferential activation of tumour control signalling pathways – Nature Nanotechnology

Barber, G. N. STING: infection, inflammation and cancer. Nat. Rev. Immunol. 15, 760–770 (2015).Article  CAS  PubMed  ...

Top News

Controlled adsorption of multiple bioactive proteins enables targeted mast cell nanotherapy – Nature Nanotechnology

Ramsey, A. V., Bischoff, A. J. & Francis, M. B. Enzyme activated gold nanoparticles for versatile site-selective bioconjugation. J. Am. Chem. Soc. 143, 7342–7350...

New advance in targeted cancer therapy using innovative immune-activating nanoparticles

Dec 30, 2023 (Nanowerk News) A groundbreaking study led by Professor Sebyung Kang and Professor Sung Ho Park in the Department of Biological Sciences at...

Privacy-Conflict Resolution for Integrating Personal- and Electronic Health Records in Blockchain-Based Systems

Susskind RE, Susskind D. The future of the professions: how technology will transform the work of human experts. Oxford University Press; 2015. Mercille J....

The Astonishing Behavior of Recursive Sequences | Quanta Magazine

IntroductionIn mathematics, simple rules can unlock universes of complexity and beauty. Take the famous Fibonacci sequence, which is defined as follows: It begins with...

Some Of The Russian Tu-95s Covered With Car Tires Miss Engines And Propellers

The new satellite photos of some Tu-95s covered with car tires and missing their engines have prompted new theories. Few days ago, satellite imagery of...

Beyond Biotech podcast 61 – Blood Cancer Awareness Month

On this week’s podcast, to recognize Blood Cancer Awareness Month, we have a conversation with Affimed’s CMO, Andreas Harstrick, to talk about blood cancers,...

The Week’s 10 Biggest Funding Rounds: Biotech Startup Abcuro Takes Top Spot

Want to keep track of the largest startup funding deals in 2023 with our new curated list of $100 million-plus venture deals...

CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphoma – Leukemia

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71:7–33.Article  PubMed  Google Scholar  Vose J, Armitage J,...

Weekly funding round-up! All of the European startup funding rounds we tracked this week (July 10-14) | EU-Startups

Friday is here with a new edition of our weekly VC funding overview for our CLUB members. Below you’ll find this week’s overview of...

Nkarta data adds to doubts facing ‘off-the-shelf’ cell therapies

Dive Brief: Shares of cell therapy developer Nkarta fell nearly 40% on Tuesday after the company reported its latest results from an early-stage study of...

What’s the Deal with Taurine and Longevity? – Regenexx

Home › Blog › What’s the Deal with Taurine and Longevity? Getting old is tough. As a result, a trillion-dollar industry serves us countless...

iPSC programs extend well beyond NK cell therapies

ARTICLE | Product DevelopmentBiotechs are developing over 20 types of iPSC-based cell therapies By Lauren Martz, Executive Director, Biopharma Intelligence June 15, 2023 1:12 AM...

Latest Intelligence

spot_img
spot_img

Chat with us

Hi there! How can I help you?